Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

FDA user fee and Modernisation Act.

Maria Donawa1

  • 1donawa@srd.it

Medical Device Technology
|February 11, 2003
PubMed
Summary
This summary is machine-generated.

A new law enables the Food and Drug Administration (FDA) to collect fees for medical device premarket submissions. This legislation introduces significant regulatory reforms impacting the medical device industry.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

US regulation of combination products.

Medical device technology·2010
Same author

Clinical studies in Italy.

Medical device technology·2010
Same author

Meeting US and European supplier control requirements.

Medical device technology·2009
Same author

Avoiding surprises when implementing a single quality system.

Medical device technology·2009
Same author

Addressing Eeuropean environmental legislation.

Medical device technology·2009
Same author

Addressing US and European device testing requirements.

Medical device technology·2008

Area of Science:

  • Medical Device Regulation
  • Health Policy
  • Biomedical Industry

Background:

  • The medical device industry operates under evolving regulatory frameworks.
  • Premarket submissions are critical for device approval and market access.
  • Regulatory changes can significantly influence industry operations and innovation.

Purpose of the Study:

  • To analyze a new law affecting medical device premarket submissions.
  • To discuss the regulatory reforms introduced by this legislation.
  • To evaluate the potential impact of the law on the medical device sector.

Main Methods:

  • Review of the new legislation.
  • Analysis of key regulatory reforms.
  • Commentary on the anticipated industry impact.

Related Experiment Videos

Main Results:

  • The law authorizes the Food and Drug Administration (FDA) to collect fees for premarket submissions.
  • Significant medical device regulatory reforms are introduced.
  • Potential impacts on the medical device industry are discussed.

Conclusions:

  • The new law represents a notable shift in medical device regulation.
  • Industry stakeholders should prepare for changes in submission processes and compliance.
  • The long-term effects on innovation and market dynamics warrant further observation.